160 related articles for article (PubMed ID: 34526300)
1. Lung Cancer as a Subsequent Malignant Neoplasm in Survivors of Childhood Cancer.
Ghosh T; Chen Y; Dietz AC; Armstrong GT; Howell RM; Smith SA; Mulrooney DA; Turcotte LM; Yuan Y; Yasui Y; Neglia JP
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2235-2243. PubMed ID: 34526300
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
3. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
Friedman DL; Whitton J; Leisenring W; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL; Neglia JP
J Natl Cancer Inst; 2010 Jul; 102(14):1083-95. PubMed ID: 20634481
[TBL] [Abstract][Full Text] [Related]
4. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
5. Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
Henderson TO; Fowler BW; Hamann HA; Nathan PC; Whitton J; Leisenring WM; Oeffinger KC; Neglia JP; Turcotte LM; Arnold MA; Conces MR; Howell RM; Robison LL; Armstrong GT; Alexander KA
Cancer; 2022 Jan; 128(2):373-382. PubMed ID: 34606625
[TBL] [Abstract][Full Text] [Related]
6. Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer.
Kok JL; Teepen JC; van der Pal HJ; van Leeuwen FE; Tissing WJE; Neggers SJCMM; Loonen JJ; Louwerens M; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; Jaspers MMW; van Santen HM; van der Heiden-van der Loo M; Janssens GO; Maduro JH; Bruggink AH; Jongmans MC; Kremer LCM; Ronckers CM;
JAMA Oncol; 2019 May; 5(5):671-680. PubMed ID: 30920605
[TBL] [Abstract][Full Text] [Related]
7. Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Dietz AC; Seidel K; Leisenring WM; Mulrooney DA; Tersak JM; Glick RD; Burnweit CA; Green DM; Diller LR; Smith SA; Howell RM; Stovall M; Armstrong GT; Oeffinger KC; Robison LL; Termuhlen AM
Lancet Oncol; 2019 Oct; 20(10):1420-1431. PubMed ID: 31471158
[TBL] [Abstract][Full Text] [Related]
8. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
[TBL] [Abstract][Full Text] [Related]
9. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors.
Ou JY; Bennion N; Parker K; Fair D; Hanson HA; Kepka D; Warner EL; Ramsay JM; Kaddas HK; Kirchhoff AC
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):625-633. PubMed ID: 37071501
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study.
Teepen JC; Kok JL; Kremer LC; Tissing WJE; van den Heuvel-Eibrink MM; Loonen JJ; Bresters D; van der Pal HJ; Versluys B; van Dulmen-den Broeder E; Nijsten T; Hauptmann M; Hollema N; Dolsma WV; van Leeuwen FE; Ronckers CM;
J Natl Cancer Inst; 2019 Aug; 111(8):845-853. PubMed ID: 30802904
[TBL] [Abstract][Full Text] [Related]
12. Risk of Subsequent Neoplasms During the Fifth and Sixth Decades of Life in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Whitton JA; Friedman DL; Hammond S; Armstrong GT; Leisenring W; Robison LL; Neglia JP
J Clin Oncol; 2015 Nov; 33(31):3568-75. PubMed ID: 26261260
[TBL] [Abstract][Full Text] [Related]
13. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study.
Termuhlen AM; Tersak JM; Liu Q; Yasui Y; Stovall M; Weathers R; Deutsch M; Sklar CA; Oeffinger KC; Armstrong G; Robison LL; Green DM
Pediatr Blood Cancer; 2011 Dec; 57(7):1210-6. PubMed ID: 21384541
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
16. Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.
Oeffinger KC; Stratton KL; Hudson MM; Leisenring WM; Henderson TO; Howell RM; Wolden SL; Constine LS; Diller LR; Sklar CA; Nathan PC; Castellino SM; Barnea D; Smith SA; Hutchinson RJ; Armstrong GT; Robison LL
J Clin Oncol; 2021 Jul; 39(20):2266-2275. PubMed ID: 33630659
[TBL] [Abstract][Full Text] [Related]
17. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study.
Neglia JP; Friedman DL; Yasui Y; Mertens AC; Hammond S; Stovall M; Donaldson SS; Meadows AT; Robison LL
J Natl Cancer Inst; 2001 Apr; 93(8):618-29. PubMed ID: 11309438
[TBL] [Abstract][Full Text] [Related]
18. Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
Henderson TO; Oeffinger KC; Whitton J; Leisenring W; Neglia J; Meadows A; Crotty C; Rubin DT; Diller L; Inskip P; Smith SA; Stovall M; Constine LS; Hammond S; Armstrong GT; Robison LL; Nathan PC
Ann Intern Med; 2012 Jun; 156(11):757-66, W-260. PubMed ID: 22665813
[TBL] [Abstract][Full Text] [Related]
19. Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
Madenci AL; Dieffenbach BV; Liu Q; Yoneoka D; Knell J; Gibson TM; Yasui Y; Leisenring WM; Howell RM; Diller LR; Krull KR; Armstrong GT; Oeffinger KC; Murphy AJ; Weil BR; Weldon CB
Cancer; 2019 Nov; 125(21):3873-3881. PubMed ID: 31322729
[TBL] [Abstract][Full Text] [Related]
20. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age.
Kok JL; Teepen JC; van Leeuwen FE; Tissing WJE; Neggers SJCMM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; van der Heiden-van der Loo M; Aleman BMP; Daniels LA; Haasbeek CJA; Hoeben B; Janssens GO; Maduro JH; Oldenburger F; van Rij C; Tersteeg RJHA; Hauptmann M; ; Kremer LCM; Ronckers CM
Neuro Oncol; 2019 Feb; 21(3):392-403. PubMed ID: 30099534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
